Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PHD finger protein 6 (PHF6) is a highly conserved nuclear protein containing two atypical PHD (plant homeodomain)-like zinc finger domains. It belongs to the chromatin-regulating protein family and is implicated in transcriptional regulation and chromatin remodeling, acting through protein–protein interactions, recognition of modified histones, and direct DNA binding. PHF6 regulates chromatin state to enable or restrict access of transcription factors, controls transcription of target genes, and plays critical roles in both hematopoietic stem/progenitor cell homeostasis and neuronal development. Germline mutations in PHF6 cause Börjeson–Forssman–Lehmann syndrome, an X-linked intellectual disability disorder, with additional roles identified as a tumor suppressor in various leukemias. Loss of PHF6 leads to increased genomic and phenotypic plasticity, contributing to malignancy and drug resistance[1][2][3][4][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PHD finger protein 6 (PHF6).